Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study

Abstract

The results of this study may be used to simplify treatment recommendations from the CGP reports and help select patients for testing, thereby increasing the accuracy of personalized medicine.